Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Here Is Actual Information, Not PR BS

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Oct 26, 2021 9:00am

79 Views

Post# 34048763

RE:Here Is Actual Information, Not PR BS

Rosenberg must have missed this....so let me post it again....I'm sure he'd love to comment on an actual factual analysis.....

Mil_Man54 wrote:
Here's the type of analysis that Rosenberg will never post.....it conflicts with his pumper agenda.....this board should povide info....good or bad....

FSD Pharma Inc. stock price down 3.24% on Friday
(Updated on Oct 22, 2021)

Sell candidate since 2021-10-22 PDF

The FSD Pharma Inc. stock price fell by -3.24% on the last day (Friday, 22nd Oct 2021) from $1.85 to $1.79. and has now fallen 4 days in a row. During the day the stock fluctuated 4.55% from a day low at $1.76 to a day high of $1.84. The price has fallen in 6 of the last 10 days and is down by -2.72% for this period. Volume has increased on the last day by 14 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 81 thousand shares were bought and sold for approximately $144.92 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.76 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -11.94% during the next 3 months and, with a 90% probability hold a price between $1.55 and $1.90 at the end of this 3-month period.